Cambridge-based health technology innovator MindMics has announced the issuance of its latest patent titled "System and Method for Cardiovascular Monitoring and Reporting." The patent introduces an advanced cardiovascular monitoring system using acoustic sensors embedded in noise-cancelling earbuds.
By integrating these sensors with AI algorithms, the system enables continuous and non-invasive monitoring of heart functions, providing accurate analysis and prediction of blood pressure and other key indicators.
MindMics aims to make advanced health monitoring widely accessible by developing adaptable algorithms and software solutions for earbud use. The technology addresses global health challenges, particularly the rising prevalence of hypertension and cardiovascular diseases. MindMics' Infrasonic Hemodynography (IH) technology, central to the patent, has undergone extensive validation against gold-standard medical assessments, demonstrating efficacy in various cardiovascular diseases.
Leveraging low-frequency acoustic biosignals detected in the ear canal, MindMics' IH technology aligns with the growing earbud market, offering a non-invasive method for comprehensive cardiovascular monitoring. The patent positions MindMics at the forefront of transforming cardiovascular health monitoring with accessible and efficient solutions for early detection and management of heart conditions.
Click here to read the original news story.